AKT1 and central nervous system cancer: Another in vitro study reported that in glioma-initiating cells, the repression of PI3K/AKT/mechanistic target of rapamycin (mTOR) signaling and sonic hedgehog signaling markedly reduced cell survival, renewal capacity and tumorigenic potential (Nanta et al. 2019).